Food Or Edible As Carrier For Pharmaceutical Patents (Class 424/439)
-
Patent number: 7972808Abstract: The present invention describes a protein hydrolysate which is rich in tripeptides whereby the tripeptides are rich in proline at one end of the peptide.Type: GrantFiled: February 29, 2008Date of Patent: July 5, 2011Assignee: DSM IP Assets B.V.Inventors: Luppo Edens, Petrus Jacobus Theodorus Dekker, Andre Leonardus De Roos
-
Patent number: 7972618Abstract: An edible water-soluble film is provided. The film includes at least one water-soluble polymer, and a foam reducing flavoring agent, wherein the film is free of added anti-foaming or defoaming agents.Type: GrantFiled: September 20, 2007Date of Patent: July 5, 2011Assignee: MonoSol Rx, LLCInventors: Richard C. Fuisz, Joseph M. Fuisz, Garry L. Myers
-
Patent number: 7968112Abstract: A lipid preparation including a glycerophospholipid or salt, conjugate and derivatives thereof, particularly phosphatidylserine (PS), phosphatidyicholine (PC), phosphatidylethanolamine (PE), phosphatidyl-inositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA), and poly-unsaturated fatty acid (PUFA) acyl groups, particularly long-chain poly-unsaturated fatty acid (LC-PUFA) acyl groups such as omega-3 and/or omega-6 acyl groups, wherein said PUFA is covalently bound to said glycerophospholipid. The preparation possesses an improved bioactivity, and is useful in the treatment of various cognitive and mental conditions and disorders and for maintenance of normal functions of brain-related systems and processes.Type: GrantFiled: October 15, 2007Date of Patent: June 28, 2011Assignee: Enzymotec Ltd.Inventors: Gai Ben Dror, Dorit Plat, Orly Farkash, Rassan Zuabi, Zohar Bar-On, Avidor Shulman, Dori Pelled
-
Patent number: 7968125Abstract: The present invention is drawn to an ephedra- and artificial stimulant-free energy promoting composition, comprising effective amounts of a magnesium amino acid chelate, a B vitamin, a pyruvate salt, and rhodiola. These ingredients work synergistically together to provide energy, without the use of artificial stimulants, caffeine, or ephedrine. Additional amino acid chelates can also be present, such as iron amino acid chelate, zinc amino acid chelate, copper amino acid chelate, manganese amino acid chelate, chromium amino acid chelate, and mixtures of second amino acid chelates.Type: GrantFiled: November 20, 2008Date of Patent: June 28, 2011Assignee: Janeel HendersonInventors: Janeel Henderson, DeWayne Ashmead
-
Publication number: 20110150968Abstract: A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip.Type: ApplicationFiled: June 18, 2010Publication date: June 23, 2011Inventor: Alessandra Grassi
-
Patent number: 7964189Abstract: The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of vitamins, minerals, lycopene, co-enzyme Q10, DHA, docusate (such as docusate sodium), folic acid, and a nutritionally acceptable carrier therefor. The invention includes specific nutritional supplements for the uses set forth above.Type: GrantFiled: September 19, 2008Date of Patent: June 21, 2011Assignee: Argent Development Group, LLCInventors: John C. Morrison, Kenneth R. Greathouse
-
Patent number: 7964224Abstract: The present invention relates generally to herbal materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. Particularly, the present invention relates generally to Hydrstatis canadensis (goldenseal) materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. More particularly, the present invention relates a process which allows the precise standardization of at least two marker compounds, berberine and hydrastine, in both hydro-alcoholic tinctures and solid extracts in the processing of goldenseal materials to produce extracts which qualify as pharmaceutical grade compositions which are suitable for use in clinical or veterinary settings to treat and/or ameliorate diseases, disorders or conditions.Type: GrantFiled: March 3, 2005Date of Patent: June 21, 2011Inventor: Randy L. Beavers
-
Patent number: 7960137Abstract: Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media.Type: GrantFiled: January 25, 2010Date of Patent: June 14, 2011Assignee: Biogala ABInventors: Eamonn Connolly, Bo Mollstam
-
Patent number: 7959962Abstract: The invention relates to long-chain inulin and its preparation from artichoke roots, its use in foodstuffs and cosmetic preparations and foodstuffs and cosmetic preparations having the long-chain inulin.Type: GrantFiled: April 12, 2006Date of Patent: June 14, 2011Assignee: Bayer CropScience AGInventors: Elke Hellwege, Roger Peeters, Jens Pilling
-
Patent number: 7960148Abstract: The invention relates to polypeptides having glucanase, e.g., endoglucanase, mannanase, xylanase activity or a combination of these activities, and polynucleotides encoding them. In one aspect, the glucanase activity is an endoglucanase activity (e.g., endo-1,4-beta-D-glucan 4-glucano hydrolase activity) and comprises hydrolysis of 1,4-beta-D-glycosidic linkages in cellulose, cellulose derivatives (e.g., carboxy methyl cellulose and hydroxy ethyl cellulose) lichenin, beta-1,4 bonds in mixed beta-1,3 glucans, such as cereal beta-D-glucans or xyloglucans and other plant material containing cellulosic parts. In addition, methods of designing new enzymes and methods of use thereof are also provided. In alternative aspects, the new glucanases e.g., endoglucanases, mannanases, xylanases have increased activity and stability at increased pH and temperature.Type: GrantFiled: July 2, 2004Date of Patent: June 14, 2011Assignees: Verenium Corporation, Syngenta Participations AGInventors: Brian Steer, Walter Callen, Shaun Healey, Derrick Pulliam
-
Patent number: 7959951Abstract: The invention relates to nitric oxide (NO) stimulating extracts from various plants. Such extracts contain compounds known as healthin I and healthin II. Specifically, the invention provides partially purified plant extracts that have NO stimulating activity, methods of isolating and partially purifying such extracts from plant materials. In addition, the invention provides methods and materials for treating diseases and conditions that require modification of cellular levels of NO, for example, diseases and conditions involving inflammation.Type: GrantFiled: August 19, 2003Date of Patent: June 14, 2011Assignee: The Research Foundation at State University of New YorkInventors: George B. Stefano, Wei Zhu, Kirk Mantione
-
Patent number: 7955625Abstract: A canola protein isolate having a protein content of at least about 90 wt % (N×6.25), preferably at least about 100 wt %, and consisting predominantly of the 2S protein and substantially free from the 7S and 12S proteins is prepared. In one aspect, canola oil seed meal is extracted with aqueous protein solution at an elevated temperature to preferentially extract 2S protein from the meal to produce a canola protein solution containing predominantly 2S protein. The 2S canola protein is recovered as an isolate. In another aspect, the canola oil seed meal is extracted with aqueous saline solution to extract 2S, 7S and 12S proteins from the meal. The aqueous protein extract solution is heat treated at an elevated temperature to precipitate 7S and 12S proteins and leave a 2S protein solution from which the isolate may be recovered. In a further aspect, the aqueous protein solution is concentrated prior to the heat treatment.Type: GrantFiled: January 28, 2008Date of Patent: June 7, 2011Assignee: Burcon NutraScience (MB) Corp.Inventors: Brandy Gosnell, Kevin I. Segall, Martin Schweizer
-
Patent number: 7955617Abstract: Blast Induced Traumatic Brain Injury or bTBI needs objective and subjective testing that can be made quickly in the field. Subjective tests using shapes, textures, tastes and odors as disposable, edible candies on a stick may be carried in a field kit. An objective test that employs a similar candy on a stick bearing antibodies bound to bioluminescent marker reads whether molecules believed to be released into the mouth from an injured brain are present if they bind to the specific antibody which may then be read.Type: GrantFiled: August 6, 2007Date of Patent: June 7, 2011Assignee: Alliant Techsystems Inc.Inventors: Daniel B. Karron, Robert D. Eisler
-
Patent number: 7955632Abstract: A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture.Type: GrantFiled: November 14, 2007Date of Patent: June 7, 2011Assignee: Bayer B.V.Inventors: Neil E. Paulsen, Roland Johnson, Michael Coffee
-
Patent number: 7947303Abstract: A supplement to be administered enterally to maintain or restore the intestinal intestinal barrier of the critically or chronically ill and people with malnutrition is described. This contains as solution, in each case based on a daily dose, a) glutamine and/or glutamine precursors in an amount in the range from 15 to 70 g, b) at least two representatives from the group of substances having antioxidant activity, and c) short-chain fatty acids and/or precursors of short-chain fatty acids in an amount of from 0.5 to 10 g.Type: GrantFiled: November 14, 2001Date of Patent: May 24, 2011Assignee: Fresenius Kabi Deutschland GmbHInventors: Barbara Kessler, Angelika Riedel, Ulrich Suchner
-
Patent number: 7947736Abstract: Method for the synthesis of a compound of formula H(OCH[CH3]CH2C[O])3—O-A-O—R wherein A is the residue of 1,3-butandiol and R is H or H(OCH[CH3]CH2C[O]3—. The method comprises reacting a cyclic oligomer of (R)-3-hydroxybutyrate consisting of (R)-3-hydroxybutyrate moieties with a 1,3-butandiol in an organic solvent in the presence of Candida antarctica lipase type B in a furan or pyran solvent.Type: GrantFiled: July 15, 2005Date of Patent: May 24, 2011Assignee: BTG International LimitedInventor: Richard A. Gross
-
Patent number: 7947803Abstract: The present invention provides an apparatus for recovering a polymer from polymer solution, and a method of recovering a polymer using the apparatus. The apparatus includes a polymer solution-storage tank for storing a polymer solution; a polymer solution feeding pump for pumping the polymer solution from the polymer solution storage tank; an antisolvent storage tank for storing an antisolvent; an antisolvent feeding pump for pumping the antisolvent from the antisolvent storage tank; a reaction chamber to which the polymer solution pumped by the polymer solution feeding pump and the antisolvent pumped by the antisolvent feeding pump are supplied; a high-speed mixer that is rotated in the reaction chamber at a speed range of 1000 to 30000 rpm, mixes the polymer solution with the antisolvent under a shearing force corresponding to a tip speed of 5 to 30 m/sec, and precipitates a polymer; and a precipitate storage tank for storing the precipitation mixture of the polymer and the solvent/antisolvent.Type: GrantFiled: December 5, 2007Date of Patent: May 24, 2011Assignee: LG Chem, Ltd.Inventors: Sung-Don Hong, In-Su Lee, Jong-Ku Lee, Sung-Ho Chun, Seung-Young Park, Sung-Cheol Yoon
-
Patent number: 7947737Abstract: This invention relates to a method of treating hypertension and reducing serum lipase activity by dietary supplementation with conjugated linoleic acid. The method comprises administering a safe and effective amount of conjugated linoleic acid to a human. The conjugated linoleic acid may be provided in the form of a free fatty acid or chemical derivatives thereof in a pill, or as a component of a prepared food product.Type: GrantFiled: September 30, 1999Date of Patent: May 24, 2011Assignee: Aker Biomarine ASAInventors: Jan Wadstein, Jan Remmereit
-
Patent number: 7943163Abstract: A medical food and/or nutritional supplement for oral administration by mammals includes ?-lipoic acid, linolenic acid complex, biotin, and coenzyme Q-10. A preferred method of manufacturing the medical food or nutritional supplement is by separate microencapsulation of one or more of the components followed by encapsulation of the individual components, for oral administration. Other methods of delivery include packaging in impermeable, disposable packets and mixing the formulations with food or a cold liquid.Type: GrantFiled: August 22, 2007Date of Patent: May 17, 2011Assignee: Response Scientific, Inc.Inventors: Gregory D. Webster, Emmanuel C. Opara
-
Patent number: 7943186Abstract: Hydroxycitric acid compositions which comprise approximately 14 to 26% by weight of calcium, and approximately 24 to 40% by weight of potassium or approximately 14 to 24% by weight of sodium, or a mixture thereof, each calculated as a percentage of the total hydroxycitric acid content of the composition, together with dietary supplements and food products containing such compositions and methods for utilizing such compositions, dietary supplements and food products to reduce body weight in mammals are disclosed.Type: GrantFiled: August 22, 2005Date of Patent: May 17, 2011Assignee: Interhealth Nutraceuticals, Inc.Inventor: G. Ganga Raju
-
Patent number: 7943164Abstract: A composition and method for treating diabetes and metabolic disorders, and for achieving weight loss in a subject comprising a combination of naturally occurring compounds is provided.Type: GrantFiled: March 11, 2008Date of Patent: May 17, 2011Inventors: Milton Joseph Ahrens, Daryl Lee Thompson
-
Publication number: 20110111009Abstract: A method of preparing and composition of bioavailable hydrophobic, poorly water soluble drugs. It uses for example, lecithin, sterol, a calcium salt, and solvent; mixing to form liposomes and then the solvent driven off; the ratios used and physical form differ from others, and maximize performance.Type: ApplicationFiled: January 20, 2011Publication date: May 12, 2011Applicant: ZOMANEX LLCInventor: CURTIS A. SPILBURG
-
Patent number: 7939099Abstract: A long-acting improver of muscular fatigue characterized by comprising 4 kinds of amino acids made up of leucine, isoleucine, valine and glutamine, and a whey protein component (whey protein and/or decomposition product of whey protein). At least one of a whey protein isolate (WPI), a whey protein concentrate (WPC), ?-lactoglobulin, and ?-lactalbumin is used as the whey protein. Novel food or drink, and pharmaceuticals which exhibit sustained recovery effects on muscular fatigue are provided.Type: GrantFiled: December 2, 2003Date of Patent: May 10, 2011Assignees: Meiji Dairies Corporation, Kyowa Hakko Bio Co. Ltd.Inventors: Hiroshi Tsuchita, Masato Saito, Toshikazu Kamiya, Miho Komatsu
-
Publication number: 20110104237Abstract: Black beans B are coated with a mineral layer 1 containing calcium powder and dolomite powder, a dough layer 2 formed by roasting a dough mixture containing flour, and an outside layer 3 formed by solidifying a seasoning mixture containing, for example, soymilk powder and powdered tea with hardened fat or oil. In 30 parts by weight of black beans, from 2 to 5, both inclusive, parts by weight of the calcium powder, from 30 to 45, both inclusive, parts by weight of the dolomite powder, and from 5 to 15, both inclusive, parts by weight of the soymilk powder, are contained.Type: ApplicationFiled: April 27, 2009Publication date: May 5, 2011Applicant: ISHIKAWA CO., LTD.Inventors: Junji Ohtani, Ikuko Ishikawa
-
Patent number: 7935365Abstract: This invention provides a preparation comprising serine glycerophospholipids which comprise a mixture of serine glycerophospholipids comprising eicosapentaenoic acid (EPA) and serine glycerophospholipids comprising docosahexaenoic acid (DHA), wherein each such serine glycerophospholipid comprising EPA and each such serine glycerophospholipid comprising DHA has the formula (I): wherein R? is serine; wherein one of R or R? is acyl EPA or acyl DHA and the other of R or R? is hydrogen or an acyl group; wherein the combined amount of EPA and DHA present in such mixture of serine glycerophospholipids constitutes 10-50% by weight of the total fatty acids content of the serine glycerophospholipids in said preparation; and wherein the mixture is not identical to naturally occurring human or mammalian brain PS.Type: GrantFiled: June 24, 2008Date of Patent: May 3, 2011Assignee: Enzymotec, Ltd.Inventors: Gai Ben Dror, Dorit Platt, Orly Farkash, Rassan Zuabi, Zohar Bar-On, Avidor Shulman, Dori Pelled, Yael Richter
-
Patent number: 7935064Abstract: Muscle cramps can be reduced or avoided by monitoring the concentration of salt in perspiration to indicate the degree of salt depletion. Based on the degree of salt depletion, a sufficient amount of rehydration beverage is consumed to normalize the salt level.Type: GrantFiled: July 31, 2008Date of Patent: May 3, 2011Assignee: Stokely-Van Camp, Inc.Inventors: Robert Murray, John R. Stofan, IV, Jeffrey J. Zachwieja, Craig A. Horswill, Myron C. Rapkin, Wayne W. Weber
-
Patent number: 7935362Abstract: Methods and products for delivering a medicament or agent to an individual are provided as well as methods for producing the product. The product includes one or more coatings having a medicament or agent. The coatings can further comprise one or more fat-based confectioneries to provide a coated product that has an improved aesthetic and taste appeal to a consumer. The medicament or agent is present within a coating that surrounds a consumable center. By chewing the coated product, the medicament or agent is released from the product within the buccal cavity.Type: GrantFiled: November 9, 2005Date of Patent: May 3, 2011Assignee: Wm. Wrigley Jr. CompanyInventors: Ronald L. Ream, Leonard Matulewicz, William J. Wokas, Brian Ream
-
Patent number: 7931912Abstract: An enteral nutrition product is provided for enteral administration directly to the stomach or intestines of a patient from an external container upon the application of pressure to the external container. The enteral nutrition product is a semi-solid material having a substantially self-supporting consistency that deforms under an externally applied load without liquefying and that is capable of containing a higher concentration of a nutrient component than a fluid. The semi-solid material includes a mixture of a nutrient solution and a semi-solidifying agent that is one of agar and a whole egg. The self-supporting consistency of the semi-solid enteral nutrition product remains substantially unchanged before, during, and after being enterally administered into the patient, and is further maintained within the stomach or the intestines of the patient such that the enteral nutrition product does not liquefy due to the body temperature of the patient.Type: GrantFiled: April 16, 2004Date of Patent: April 26, 2011Inventor: Jiro Kanie
-
Publication number: 20110091522Abstract: An edible chew pill jacket receives a pill/tablet or capsule that is to be administered to a pet, animal or human. The edible chew pill jacket includes a flexible top wall, side walls and bottom wall configured to form a chamber appointed to receive a pill. A flexible longitudinal slit is integrated within the top wall for providing access to the chamber for insertion of the pill within the edible chew pill jacket. The edible chew pill jacket is formulated with at least one flavoring to provide a tasty treat appointed to mask the pill's taste. The chew pill jacket substantially encapsulates the pill/tablet appointed to be orally ingested. The chew pill jacket may include medicament therein, nutrients, vitamins, or may simply be provided as a tasty treat to mask the taste of the pill.Type: ApplicationFiled: October 16, 2009Publication date: April 21, 2011Inventor: Marni Markell Murwitz
-
Publication number: 20110091521Abstract: An edible spoon for dissociating into consumable predetermined clumps in order to prevent dissociating into random granules that would make consumption more difficult. The edible spoon includes a bowl and a handle. The bowl extends from the handle and contains weakened lines. The weakened lines in the bowl define the consumable predetermined clumps so as to allow the bowl to dissociate into the consumable predetermined clumps in order to prevent dissociating into the random granules that would make the consumption more difficult.Type: ApplicationFiled: April 12, 2010Publication date: April 21, 2011Inventor: Anatoliy Omelchenko
-
Patent number: 7927636Abstract: Hydroxycitric acid compositions which comprise approximately 14 to 26% by weight of calcium, and approximately 24 to 40% by weight of potassium or approximately 14 to 24% by weight of sodium, or a mixture thereof, each calculated as a percentage of the total hydroxycitric acid content of the composition, together with dietary supplements and food products containing such compositions and methods for utilizing such compositions, dietary supplements and food products to reduce body weight in mammals are disclosed.Type: GrantFiled: July 13, 1998Date of Patent: April 19, 2011Assignee: Interhealth Nutraceuticals, Inc.Inventor: G. Ganga Raju
-
Publication number: 20110086809Abstract: A method for supporting retinal, intestinal, and/or nervous system development in a neonate is provided. The method involves enterally administering arginine-glutamine dipeptide to a neonate.Type: ApplicationFiled: October 14, 2009Publication date: April 14, 2011Inventors: Joshua Anthony, Kristin Morris, Maria Grant, Joseph Neu
-
Patent number: 7923041Abstract: Disclosed are compositions for promoting general health and well-being, comprising an extract of a botanical raw material, wherein said extract inhibits the carboxyl demethylating activity of a protein phosphatase, and methods of making and using same.Type: GrantFiled: August 3, 2007Date of Patent: April 12, 2011Assignees: Signum Biosciences, Inc., The Trustees of Princeton UniversityInventors: Jeffry Stock, Maxwell Stock, Haoming Gu, Zhu Li, Peter Wolanin
-
Patent number: 7923042Abstract: The present invention relates to a medicated gauze containing as active ingredient, aliantoin, a Centella asiatica extract and, optionally, an Urtica dioica extract.Type: GrantFiled: July 20, 2006Date of Patent: April 12, 2011Assignee: Svas Biosana S.R.L.Inventor: Guglielmo Cozzolino
-
Patent number: 7923024Abstract: The present invention relates to a mineral composition, characterized in that the mineral composition comprises 100 parts by weight of a metal salt having a solubility product in water at 25° C. of 1.0×10?7 or less and 0.5 to 50 parts by weight of an emulsifier having an HLB of 6 to 10, wherein the metal salt comprises fine particles having an average particle size of 0.05 to 1 ?m.Type: GrantFiled: July 10, 2003Date of Patent: April 12, 2011Assignee: Taiyo Kagaku Co., Ltd.Inventors: Naoteru Honda, Kazuaki Sakaguchi, Katsuyasu Nakata, Hironobu Nanbu
-
Publication number: 20110081400Abstract: A nutritional composition particularly suitable for use by morbidly obese patients pre and post bariatric surgery comprises 20-60 wt % protein source, 15-55 wt % carbohydrate, 10-20 wt % soluble dietary fibres, less than 10 wt % fat and micronutrients. The micronutrients comprise 0.75-3 wt % calcium, 0.5-1.8 wt % phosphorus, 12.5-100 mg/100 g of iron, 10-100 mcg/100 g vitamin D, and 175-560 mcg/100 g vitamin B12 the wt % being based on the dry weight of the total composition.Type: ApplicationFiled: December 13, 2010Publication date: April 7, 2011Inventors: Jane Elizabeth LANGFORD, Faith Farayi TAKURUKURA, Catherine Louise PATTERSON, Sandra Helen GIFFEN, Fredrick Joel BRODY
-
Patent number: 7919128Abstract: Disclosed is a powdered composition including an emulsifier and at least one anti-caking additive selected from the group consisting of earth alkali oxides, earth alkali hydroxides or a mixture thereof. Further disclosed is a method for preventing caking of a powdered composition comprising emulsifiers.Type: GrantFiled: March 15, 2002Date of Patent: April 5, 2011Assignee: Puratos Naamloze VennoostschapInventors: François Heroufosse, Emmanuel Vanzeveren
-
Patent number: 7919479Abstract: Provided is a pharmaceutical or dietetic product, which serves for reducing and/or blocking the adhesion of pathogenic substances and organisms to eucaryontic cells, in particular mammal cells. Said preparation contains at least one carbohydrate having an uronic acid unit on one of the ends thereof. 10 to 100% of the present, terminal uronic acid units pertaining to the carbohydrates are provided with a double bond that is especially situated between the C4 and C5 atom.Type: GrantFiled: August 29, 2006Date of Patent: April 5, 2011Assignee: N. V. NutriciaInventors: Bernd Stahl, Gunther Boehm
-
Patent number: 7910140Abstract: The alkali metal salts form of ?-acids dissolved in propylene glycol is used to control microbial growth in food products, process streams and other applications, including in cosmetic formulations.Type: GrantFiled: November 13, 2006Date of Patent: March 22, 2011Assignee: S.S. Steiner, Inc.Inventors: Richard J. H. Wilson, Robert J. Smith, Gerhard Haas
-
Patent number: 7901716Abstract: Provided is a composition that contains, as an active ingredient, an extract or polysaccharides separated from the leaves and/or stems of plants belonging to Panax genus, for an anticancer drug or its adjuvant, having an effect on the activity of hematopoiesis enhancement, cancer metastasis inhibition, bone marrow defense, etc. . . . , and a process for preparation of the extract from the leaves and/or stems of plants belonging to Panax genus.Type: GrantFiled: May 28, 2003Date of Patent: March 8, 2011Assignee: MD Bioalpha Co., Ltd.Inventors: Tae Hwan Kwak, Myoung Sook Shin, Ji Yeon Kim, Jong-Kook Park
-
Patent number: 7897169Abstract: To provide a food which suitably supply ubiquinol, a substance indispensable to the living body but is liable to be decreased and fall short of the requirements, through ingestion in the same ways as the ordinary foods in daily living. A ubiquinol-enriched oil/fat-containing food.Type: GrantFiled: January 20, 2003Date of Patent: March 1, 2011Assignee: Kaneka CorporationInventors: Yasuyoshi Ueda, Shiro Kitamura, Tadayoshi Shiraishi, Masayuki Abe, Takeshi Kawashima, Toshinori Ikehara
-
Patent number: 7897177Abstract: A particulate fiber composition containing at least one first dietary fiber, coated by an insoluble dietary fiber or a dietary fiber with low solubility, serving to prevent dissolution of the fiber composition in the oral cavity and during passage through the esophagus. The fiber composition has one or several inserted additional layers of at least one second dietary fiber between the at least one first dietary fiber and the coating of the insoluble dietary fiber/dietary fiber of low solubility. The different properties of solubility and fermentability of the fibers are utilized for the production of multilayer particles. The dietary fiber composition can be used as a supplement applied in pharmaceuticals and food products where high fiber content and small calorie content is given a high priority. Furthermore, the dietary fiber supplement can be applied for replacement of part of the sugar in sugar coatings of generally known cereals.Type: GrantFiled: October 19, 2004Date of Patent: March 1, 2011Assignee: Medic House Cambrige LtdInventors: Lasse L. Hessel, Jesper Malling, Eivind Gudmand-Høyer
-
Patent number: 7897154Abstract: Dermal drops that, when applied topically to animal subjects, can ameliorate symptoms of conditions such as diabetes and Parkinson's disease are prepared as concentrates of the culture filtrate of a Basidiomycete fungus grown under appropriate conditions. The concentrate can also be used as a convenient source of liquid compost factor.Type: GrantFiled: August 9, 2007Date of Patent: March 1, 2011Assignee: ABR, LLCInventor: Bryan Hiromoto
-
Patent number: 7887852Abstract: The present invention is directed to soft gel compositions, methods of delivery and packaged nutraceuticals of the soft gel compositions that include at least one polymethoxylated flavone and, optionally, at least one tocotrienol. Optional active ingredients include a phytosterol, DHA, EPA, coenzyme Q-10 or an analog thereof and mixtures thereof.Type: GrantFiled: July 7, 2005Date of Patent: February 15, 2011Assignee: Soft Gel Technologies, Inc.Inventor: Ronald G. Udell
-
Patent number: 7887856Abstract: A composition for treating cancer cells and a preparation method therefor are provided. The novel flavonoid compounds are obtained from natural plants, and more particularly the compounds have a cytotoxicity on cancer cells.Type: GrantFiled: November 16, 2009Date of Patent: February 15, 2011Assignee: Kaohsiung Medical UniversityInventors: Yang-Chang Wu, An-Shen Lin, Fang-Rong Chang, Chin-Chung Wu
-
Patent number: 7883697Abstract: The present invention relates to the use of compositions comprising receptor ligands obtainable by a process comprising fermenting a food material, comprising animal milk or vegetable proteins, with lactic acid bacteria to obtain a fermented food or feed material that comprises ligands of specific adrenoreceptors and/or serotonin receptors. The fermented food or feed material is useful e.g. for reducing and/or stabilizing heart rate in a mammal. It may furthermore be used for treatment and/or relief of erectile dysfunctions and for treatment and/or relief of benign prostate hypertrophy (BPH), in a mammal.Type: GrantFiled: September 5, 2005Date of Patent: February 8, 2011Assignee: CHR-Hansen A/SInventor: Bénédicte Flambard
-
Patent number: 7883708Abstract: A novel substance that has the physiological activity of the aglycone of isoflavones and the physiological activity of the culture of the basidiomycetes with the physiological activities being synergistically enhanced, obtained by cultivating a basidiomycetes having a ?-glucosidase activity in a medium containing an isoflavone, a method for producing it, and food, feedstuff and medicine containing it. The substance of the invention is improved in the physiological effect of the aglycone of isoflavones and the physiological effect of the culture of the basidiomycetes, and is not only useful as an anti-tumor agent but also is useful for therapy and/or prevention of osteoporosis and also as an immune enhancement agent.Type: GrantFiled: April 24, 2008Date of Patent: February 8, 2011Assignee: Amino Up Chemical Co., Ltd.Inventors: Ken-ichi Kosuna, Lan Yuan, Takehito Miura, Buxiang Sun
-
Patent number: 7884083Abstract: The invention relates to new immunomodulatory compositions which comprise a cationic condensing agent, an immunomodulatory compound, and a stabilizing agent. The compositions of the invention typically form particles which have increased immunomodulatory activity as compared to immunomodulatory compounds not formulated in the compositions of the invention. Also provided are methods of making the compositions and methods for therapeutic use of the compositions.Type: GrantFiled: August 12, 2003Date of Patent: February 8, 2011Assignee: Dynavax Technologies CorporationInventors: Gary Van Nest, Stephen Tuck
-
Publication number: 20110027342Abstract: The invention relates to compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and to methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. The enhanced bioavailability formulations may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease.Type: ApplicationFiled: July 28, 2010Publication date: February 3, 2011Applicant: MSI METHYLATION SCIENCES, INC.Inventors: I. David MacDonald, Nancy Harrison, Aniko Takacs-Cox, Admir Purac, Almira Blazek-Welsh
-
Patent number: 7874995Abstract: Muscle cramps can be reduced or avoided by monitoring the concentration of salt in perspiration to indicate the degree of salt depletion. Based on the degree of salt depletion, a sufficient amount of rehydration beverage is consumed to normalize the salt level.Type: GrantFiled: November 1, 2006Date of Patent: January 25, 2011Assignee: Stokely-Van Camp, Inc.Inventors: Robert Murray, John R. Stofan, IV, Jeffrey J. Zachwieja, Craig A. Horswill, Myron C. Rapkin, Wayne W. Weber